A breakthrough in the international medical community made by NYO3 help explore the field of krill oil supplements from Norway to the whole world
Alzheimer’s disease (AD), a neurodegenerative disease that occurs mainly in the elderly, has become one of the biggest challenges in the medical field, in addition to the three chronic diseases of hyperlipidemia, hyperglycemia, and hypertension. As the population rapidly ages, the number of AD patients might increase to more than 150 million worldwide by 2050. Though AD treatment has always been a challenge for medical researchers, they are still relentlessly exploring this field and struggling to overcome this challenge.
Among international experts in the field of human aging and age-related neurodegenerative mechanisms, Prof. Evandro Fei Fan, the chief scientific and medical advisor of NYO3, is highly reputable for his research focusing on krill oil’s inhibition of neuronal loss in older AD patients and cellular senescence in other age groups. In recognition of his work, Norway’s national research award of this year was granted to him by King Harald V of Norway. He delivered a speech to share his findings at the Global Brand Celebration of NYO3.
